Pierre Raboisson

Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor

Åsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson et al. · Journal of Medicinal Chemistry · 2014 · 211 citations

Hepatitis C Virus, Immunology, Pharmacotherapy +20

<i>In Vitro</i> Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435

Oliver Lenz, Thierry Verbinnen, Tse‐I Lin et al. · Antimicrobial Agents and Chemotherapy · 2010 · 210 citations · Full text

Molecular Virology, Viral Hepatitis, Pathogenesis +14

In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor

Tse‐I Lin, Oliver Lenz, Gregory Fanning et al. · Antimicrobial Agents and Chemotherapy · 2009 · 190 citations · Full text

A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction

Suzanne J. F. Kaptein, Olivia Goethals, Dominik Kiemel et al. · Nature · 2021 · 181 citations · Full text

Ns3–ns4b Interaction, Immunology, Antiviral Drug Development +4

Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist

Anthony Baurand, Pierre Raboisson, Monique Freund et al. · European Journal of Pharmacology · 2001 · 165 citations

Thrombopoiesis, Thrombosis, Platelet Aggregation Inhibitors +12